AI Article Synopsis

  • - The study aimed to examine the clinical and immune system characteristics of patients with anti-synthetase syndrome (ASS) who also have rheumatoid arthritis (RA) compared to those without RA.
  • - Out of 104 ASS patients with arthritis, 23.1% were diagnosed with RA and displayed notable differences such as higher rates of rapidly progressive interstitial lung disease, more tender and swollen joints, and increased bone erosion compared to the non-RA group.
  • - The overlap group (ASS with RA) also had significantly altered immune cell profiles, including decreased regulatory T cells and B cells, as well as higher levels of certain inflammatory markers, leading to a lower rate of complete clinical response.

Article Abstract

Objective: To investigate the clinical and immunological characteristics of anti-synthetase syndrome (ASS) patients overlap with rheumatoid arthritis (RA).

Methods: A retrospective analysis was conducted on ASS patients with arthritis who were treated at Peking University People' s Hospital. Data collected included demographic information, clinical manifestations, laboratory features, lymphocyte subsets in peripheral blood, and treatments. The patients with ASS were divided into two groups based on the presence or absence of RA for comparative analysis.

Results: A total of 104 ASS patients with arthritis were included, among whom 23.1% (24/104) were diagnosed with RA. The ASS with RA group had a significantly higher incidence of rapidly progressive interstitial lung disease (RP-ILD) (41.7% . 17.6%, =0.032), number of tender joints [10 (7, 14) . 4 (0, 8), < 0.001], number of swollen joints [4 (2, 8) . 2 (0, 4), =0.012], and rate of bone erosion (47.8% . 2.5%, < 0.001) compared with the non-RA group. Levels of platelets [(289.57±68.74)×10/μL . (247.94±77.04)×10/μL, =0.022], erythrocyte sedimentation rate (ESR) [43 (19, 59) mm/h . 18 (10, 44) mm/h, =0.019], and C-reactive protein (CRP) [19.20 (4.80, 55.36) mg/L . 5.68 (1.10, 14.96) mg/L, =0.006] were found significantly higher in the ASS with RA group than those in non-RA group. Analysis of immune cells in peripheral blood mononuclear cell (PBMC) showed that significantly decreased proportions of CLA Treg cells [(11.12±4.10)% . (17.22±8.49)%, =0.003], B cells [8.56% (4.80%, 11.90%) . 14.55% (8.75%, 20.29%), =0.025], and natural killer (NK) cells [7.56% (4.65%, 13.20%) . 13.25% (7.46%, 19.25%), =0.045] in the overlap group compared with non-RA group. Proportion of Naïve Th cells [(52.66±17.66)% . (40.76±14.96)%, =0.033)] was significantly increased in overlap group compared with non-RA group. Overlap group had lower rate of complete clinical response than non-RA group (16.7% . 43.8%, =0.031).

Conclusion: Among ASS patients with arthritis, those with RA have more severe lung and joint involvement and a lower treatment response rate, highlighting the need for early recognition and aggressive intervention.

Download full-text PDF

Source
http://dx.doi.org/10.19723/j.issn.1671-167X.2024.06.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652992PMC

Publication Analysis

Top Keywords

non-ra group
20
ass patients
16
patients arthritis
12
compared non-ra
12
overlap group
12
group
10
anti-synthetase syndrome
8
overlap rheumatoid
8
peripheral blood
8
ass group
8

Similar Publications

Article Synopsis
  • - The study aimed to examine the clinical and immune system characteristics of patients with anti-synthetase syndrome (ASS) who also have rheumatoid arthritis (RA) compared to those without RA.
  • - Out of 104 ASS patients with arthritis, 23.1% were diagnosed with RA and displayed notable differences such as higher rates of rapidly progressive interstitial lung disease, more tender and swollen joints, and increased bone erosion compared to the non-RA group.
  • - The overlap group (ASS with RA) also had significantly altered immune cell profiles, including decreased regulatory T cells and B cells, as well as higher levels of certain inflammatory markers, leading to a lower rate of complete clinical response.
View Article and Find Full Text PDF

Objective: Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular disease (CVD) including heart failure (HF). However, little is known regarding the relative risks of heart failure subtypes such as HF with preserved (HFpEF) or reduced ejection fraction (HFrEF) in RA compared to non-RA.

Methods: We identified RA patients and matched non-RA comparators among participants consenting to broad research from two large academic centers.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to examine the prevalence of comorbidities among Arab patients with rheumatoid arthritis (RA) and to compare these rates with a control group without RA.
  • The research included 439 patients with RA and 1756 matched controls, revealing that a higher percentage of RA patients (42.8%) had at least one comorbidity compared to 36.2% in the control group.
  • Significant associations were found between RA and specific conditions like ischaemic heart disease, fibromyalgia, and cataracts, indicating RA patients have a much higher risk for these comorbidities.
View Article and Find Full Text PDF

Objective: The aim of this study was to investigate the value and reliability of superb microvascular imaging (SMI) in detecting subclinical synovial inflammation in patients with inflammatory arthritis.

Methods: All patients with inflammatory arthritis who had achieved clinical remission were retrospectively analyzed and evaluated with SMI and power Doppler ultrasound (PDUS). Subclinical synovitis was graded by a semiquantitative score (0-3) for each imaging method.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!